The nano-formulated, plant-based nutraceutical brand plans to use the capital to build India’s first “Trust over Promise” health platform, designed to demonstrate supplement efficacy through measurable consumer health outcomes.
ZeroHarm Sciences, a nano-formulated plant-based nutraceutical brand, successfully closed a 65 crore funding round. Kotak Alternate Asset Managers, through its Kotak Life Sciences Fund I, has investe… [+1565 chars]
